Release Date: 29/09/17 09:10 Summary: Notice of General Meeting/Proxy Form Price Sensitive: No Download Document 514.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%